IL-1β and CXCR4 as Potential Therapeutic Targets for Alzheimer's Disease

Background: Alzheimer's Disease (AD) is a highly prevalent form of age-related dementia. However, the underlying mechanisms of AD are largely unexplored.

Materials and methods: In this study, bioinformatics analysis was performed to identify the possible therapeutic targets for AD. The GEO database was used to screen the Differentially Expressed Genes (DEGs). Enrichment analysis, protein-protein interaction network, and LASSO model analyses were successfully performed. Furthermore, an ELISA assay was also conducted to determine the expression of principal genes within the AD and control samples.

Results: A total of 416 differentially expressed genes (DEGs) were recognized based on the GSE48350 and GSE28146 datasets. The IL-1β and CXCR4 levels were markedly elevated in the AD samples relative to the control.

Conclusion: The IL-1β and CXCR4 genes were identified as principal AD-related genes that can be targeted for anti-AD therapy.